LifeMD Inc (LFMD)

Currency in USD
12.10
-0.26(-2.06%)
Real-time Data·
LFMD Scorecard
Full Analysis
Impressive gross profit margins
Earnings results expected today
Fair Value
Day's Range
11.9112.72
52 wk Range
3.9915.84
Key Statistics
Prev. Close
12.35
Open
12.56
Day's Range
11.91-12.72
52 wk Range
3.99-15.84
Volume
1.36M
Average Volume (3m)
1.7M
1-Year Change
87.41%
Book Value / Share
-0.05
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
LFMD Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
14.00
Upside
+15.70%
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week

LifeMD Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

LifeMD Inc Company Profile

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company operates through two operating segments: Telehealth and WorkSimpli. The company offers telehealth platform comprising RexMD, a men’s telehealth brand that provides access to virtual medical treatment for a variety of men’s health needs, including erectile dysfunction, premature ejaculation, and hair loss; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; and Cleared which provides personalized treatments for allergy, asthma and immunology. It also provides LifeMD PC, a virtual primary care and telehealth service which is a provider for their primary care, urgent care, and chronic care needs; and offers virtual medical care, including on-demand consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, integration with in-home tools, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. Further, it offers GLP-1 for weight management and in-home health monitoring devices. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.

LifeMD Inc SWOT Analysis


Telehealth Triumph
LifeMD's Weight Management Program sees explosive growth, doubling subscribers and driving record patient acquisition in Q1 2024
Diversification Drive
Explore LifeMD's expansion into men's health with new HRT and weight management offerings, positioning for cross-selling opportunities
Financial Forecast
Analysts project 35% revenue growth for FY2024, with adjusted EBITDA margins expected to rise from 8% to 13.5% by FY2025
AI-Powered Scaling
Learn how LifeMD leverages AI to expand provider capacity and improve drug authorization rates, enhancing operational efficiency
Read full SWOT analysis

LifeMD Inc Earnings Call Summary for Q1/2025

  • Q1 2025 revenue of $65.7M beat forecast, EPS positive at $0.01; stock rose 3.09% in aftermarket trading
  • First positive GAAP net income reported; revenue grew 49% YoY, driven by 70% growth in telehealth segment
  • Gross margin at 86.8%; telehealth adjusted EBITDA $5.3M, consolidated adjusted EBITDA $8.7M
  • FY2025 revenue guidance: $268M-$275M; expansion planned into women's health and behavioral health verticals
  • Partnerships with Lilly and NovoCare strategic but not revenue-generating; compounding pharmacy services in development
Last Updated: 06/05/2025, 22:18
Read Full Transcript

Compare LFMD to Peers and Sector

Metrics to compare
LFMD
Peers
Sector
Relationship
P/E Ratio
−39.5x−1.1x−0.5x
PEG Ratio
−0.73−0.010.00
Price/Book
−234.8x0.5x2.6x
Price / LTM Sales
2.3x1.1x3.3x
Upside (Analyst Target)
13.4%17.1%43.5%
Fair Value Upside
Unlock5.6%6.3%Unlock

Analyst Ratings

7 Buy
1 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 14.00
(+15.70% Upside)

Earnings

Latest Release
May 06, 2025
EPS / Forecast
0.01 / -0.06
Revenue / Forecast
65.70M / 62.37M
EPS Revisions
Last 90 days

LFMD Income Statement

People Also Watch

13.71
OSCR
-0.98%
31.48
BMNR
+1.11%
15.620
ZETA
-1.14%
51.245
ASTS
-0.26%
10.26
DLO
-0.39%

FAQ

What Stock Exchange Does LifeMD Trade On?

LifeMD is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for LifeMD?

The stock symbol for LifeMD is "LFMD."

What Is the LifeMD Market Cap?

As of today, LifeMD market cap is 549.46M.

What Is LifeMD's Earnings Per Share (TTM)?

The LifeMD EPS (TTM) is -0.33.

When Is the Next LifeMD Earnings Date?

LifeMD will release its next earnings report on 04 Aug 2025.

From a Technical Analysis Perspective, Is LFMD a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has LifeMD Stock Split?

LifeMD has split 1 times.

How Many Employees Does LifeMD Have?

LifeMD has 306 employees.

What is the current trading status of LifeMD (LFMD)?

As of 05 Aug 2025, LifeMD (LFMD) is trading at a price of 12.10, with a previous close of 12.35. The stock has fluctuated within a day range of 11.91 to 12.72, while its 52-week range spans from 3.99 to 15.84.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.